Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

IMI European Lead Factory — democratizing access to high-throughput screening

The European Lead Factory combines assets and experience from major pharma with innovation and agility of academia and SMEs in a collaborative platform to expand access to high-throughput screening. With many successes heading towards the clinic, the organization is broadening its approach to screening and partnering.
  1. Philip S. Jones

    1. BioAscent Discovery, Glasgow, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. Sylviane Boucharens

    1. BioAscent Discovery, Glasgow, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  3. Stuart P. McElroy

    1. BioAscent Discovery, Glasgow, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  4. Angus Morrison

    1. BioAscent Discovery, Glasgow, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  5. Saman Honarnejad

    1. Pivot Park Screening Centre, Oss, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  6. Stan van Boeckel

    1. Pivot Park Screening Centre, Oss, the Netherlands. Present address: Leiden University, Leiden, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  7. Helma van den Hurk

    1. Pivot Park Screening Centre, Oss, the Netherlands. Present address: DeSeizoenen B.V, Oploo, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  8. Daniel Basting

    1. Bayer AG, Berlin, Frankfurt and Wuppertal, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  9. Jörg Hüser

    1. Bayer AG, Berlin, Frankfurt and Wuppertal, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  10. Stefan Jaroch

    1. Bayer AG, Berlin, Frankfurt and Wuppertal, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  11. Eckhard Ottow

    1. Bayer AG, Berlin, Frankfurt and Wuppertal, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  12. Jorg Benningshof

    1. Symeres, Groningen and Nijmegen, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  13. Rutger H. A. Folmer

    1. Symeres, Groningen and Nijmegen, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  14. Frank Leemhuis

    1. Symeres, Groningen and Nijmegen, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  15. Patricia M. Kramer-Verhulst

    1. Lygature, Utrecht, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  16. Vera J. M. Nies

    1. Lygature, Utrecht, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  17. Kristina M. Orrling

    1. Lygature, Utrecht, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  18. Ton Rijnders

    1. Lygature, Utrecht, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  19. Claudia Pfander

    1. ARTTIC S.A.S., Munich, Germany. Present address: EMBL, Heidelberg, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  20. Ola Engkvist

    1. AstraZeneca Discovery Sciences, Gothenburg, Sweden.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  21. Garry Pairaudeau

    1. AstraZeneca Discovery Sciences, Gothenburg, Sweden. Present address: Exscientia, Oxford, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  22. Peter B. Simpson

    1. AstraZeneca Discovery Sciences, Gothenburg, Sweden. Present address: Medicines Discovery Catapult, Macclesfield, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  23. Jean-Yves Ortholand

    1. Edelris, Lyon, France.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  24. Didier Roche

    1. Edelris, Lyon, France.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  25. Alexander Dömling

    1. Groningen University, Groningen, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  26. Sven M. Kühnert

    1. Grünenthal, Aachen, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  27. Peter W. M. Roevens

    1. Janssen Research & Development, Beerse, Belgium.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  28. Herman van Vlijmen

    1. Janssen Research & Development, Beerse, Belgium.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  29. Eva J. A. van Wanrooij

    1. Janssen Research & Development, Beerse, Belgium.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  30. Christophe Verbruggen

    1. Janssen Research & Development, Beerse, Belgium.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  31. Peter Nussbaumer

    1. Lead Discovery Center GmbH, Dortmund, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  32. Huib Ovaa

    1. Leiden University Medical Centre, Leiden, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  33. Mario van der Stelt

    1. Leiden University, Leiden, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  34. Klaus Baek Simonsen

    1. Lundbeck, Copenhagen, Denmark.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  35. Lena Tagmose

    1. Lundbeck, Copenhagen, Denmark.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  36. Herbert Waldmann

    1. Max Planck Institute of Molecular Physiology Dortmund, Dortmund, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  37. James Duffy

    1. Medicines for Malaria Venture, Geneva, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  38. Dirk Finsinger

    1. Merck KGaA, Darmstadt, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  39. Mirek Jurzak

    1. Merck KGaA, Darmstadt, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  40. Nicola A. Burgess-Brown

    1. University of Oxford, Oxford, United Kingdom. Present address: Exact Sciences, Oxford, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  41. Wen H. Lee

    1. University of Oxford, Oxford, United Kingdom. Present address: Action Against Age-related Macular Degeneration, London, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  42. Floris P. J. T. Rutjes

    1. Radboud University, Nijmegen, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  43. Hubert Haag

    1. Sanofi, Frankfurt, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  44. Christopher Kallus

    1. Sanofi, Frankfurt, Germany. Present address: Bayer AG, Berlin, Frankfurt and Wuppertal, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  45. Hartmut Mors

    1. Sanofi, Frankfurt, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  46. Thierry Dorval

    1. Servier Research Institute, Paris, France.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  47. Brigitte Lesur

    1. Servier Research Institute, Paris, France.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  48. Fernando Ramon Olayo

    1. Servier Research Institute, Paris, France.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  49. Daniel Hamza

    1. Sygnature Discovery, Nottingham, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  50. Geraint Jones

    1. Sygnature Discovery, Nottingham, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  51. Christopher Pearce

    1. Sygnature Discovery, Nottingham, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  52. Alexander Piechot

    1. Taros Discovery, Dortmund, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  53. Dimitrios Tzalis

    1. Taros Discovery, Dortmund, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  54. Mads H. Clausen

    1. Technical University of Denmark, Lyngby, Denmark.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  55. Jeremy Davis

    1. UCB, Braine-l'Alleud, Belgium.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  56. Daphné Derouane

    1. UCB, Braine-l'Alleud, Belgium.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  57. Céline Vermeiren

    1. UCB, Braine-l'Alleud, Belgium.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  58. Markus Kaiser

    1. University Duisburg-Essen, Essen, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  59. Robert A. Stockman

    1. University Nottingham, Nottingham, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  60. Denise V. Barrault

    1. University of Dundee, Dundee, United Kingdom. Present address: Exscientia, Oxford, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  61. Andrew D. Pannifer

    1. University of Dundee, Dundee, United Kingdom. Present address: Exscientia, Oxford, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  62. Jason R. Swedlow

    1. University of Dundee, Dundee, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  63. Adam S. Nelson

    1. University of Leeds, Leeds, United Kingdom.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  64. Romano V. A. Orru

    1. VU University Amsterdam, Amsterdam, the Netherlands. Present address: Maastricht University, Maastricht, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  65. Eelco Ruijter

    1. VU University Amsterdam, Amsterdam, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  66. Steven P. van Helden

    1. Pivot Park Screening Centre, Oss, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  67. Volkhart M. Li

    1. Bayer AG, Berlin, Frankfurt and Wuppertal, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  68. Ton Vries

    1. Symeres, Groningen and Nijmegen, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  69. Jon S. B. de Vlieger

    1. Lygature, Utrecht, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Small-molecule drug discovery begins with a therapeutic rationale but rapidly progresses to requiring chemical matter to validate the rationale and provide the chemical basis for a potential new medicine. Multiple strategies exist for generating this chemical matter, but a mainstay for more than 25 years has been diversity-based high-throughput screening (HTS)1. Due to the considerable infrastructural requirements (including a large, high-quality compound library, compound logistics expertise, and automated assay development and execution) the ability to perform such screening and the expertise to interpret and develop the output has traditionally resided within large pharma companies. The European Lead Factory (ELF) is a consortium of industry and academic partners that was set up in 2013 to expand access to and increase the application of this critical technique for lead generation.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature Reviews Drug Discovery 21, 245-246 (2022)

doi: https://doi.org/10.1038/d41573-021-00196-3

Acknowledgements

The European Lead Factory has received support from the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement no. 115489, resources of which are composed of financial contribution from the EU’s Seventh Framework Programme and EFPIA companies' in-kind contribution. This project has also received funding from the IMI-2 Joint Undertaking (JU) under grant agreement no. 806948. The JU receives support from the EU’s Horizon 2020 research and innovation programme, the EFPIA and Medicines for Malaria Venture (MMV).

Disclaimer

This communication reflects the views of the authors and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.

Updates & Corrections

  • Correction 24 January 2022: Andrew D. Pannifer was missing from the list of consortium authors, and this has been corrected.

References

  1. Macarron, R. et al. Impact of high-throughput screening in biomedical research. Nat. Rev. Drug Discov. 10, 188–195 (2011).

    Article  PubMed  Google Scholar 

  2. Brem, J. et al. Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors. Nat. Chem. https://doi.org/10.1038/s41557-021-00831-x (2021).

  3. Goutopoulos, A. et al. Abstract LB-295: Discovery of potent selective oral ACSS2 inhibitors for the treatment of acetate avid tumors. Cancer Res. 80, https://doi.org/10.1158/1538-7445.am2020-lb-295 (2020).

  4. Mullard, A. 2020 FDA approvals. Nat. Rev. Drug Discov. 20, 85–90 (2021).

    Article  PubMed  Google Scholar 

Download references

Competing Interests

The following authors are employed by companies as indicated in more detail by their affiliations: P.S.J., S.B., S.P.M, A.M., S.P.V.H., S.H., S.V.B., H.V.D.H., V.M.L., D.B., J.H., S.J., E.O., T.V., J.B., R.H.A.F., F.L., J.S.B.D.V., P.M.K.-V., V.J.M.N., K.M.O., T.R., C.P., O.E., G.P., P.B.S., J.-Y. O., D.R., S.M.K., P.W.M.R., H.V.V., E.J.A.V.W., C.V., P.N., K.B.S., L.T., D.F., M.J., N.A.B.-B., H.H., C.K., H.M., T.D., B.L., F.R.O., D.H., G.J., C.P., A.P., D.T., J.D., D.D., C.V., D.V.B. and A.D.P.

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links